Ulrike Sager

Ulrike Sager has a diverse work experience in the field of market access, specifically in Germany and Austria. Ulrike is currently working as a Consultant Market Access at Ulrike Sager Consulting since 2022. Before that, they served as the Head of Market Access for Germany and Austria at Oncopeptides AB starting from 2021. From 2017 to 2021, they worked at bluebird bio as the Director of Access, Value & Evidence Strategy focusing on Germany. Prior to this, they held the position of Lead Market Access Oncology at AbbVie from 2014 to 2017. In 2014, they briefly worked as the Head of Access for the DACH region at Swedish Orphan Biovitrum AB (Sobi). Their earlier experience includes working as the Access Lead Oncology at Pfizer starting from 2008 and as a Manager of Market Access and Reimbursement at Janssen-Cilag GmbH from 2000 to 2008. Overall, Ulrike Sager has a solid background in market access and reimbursement in the pharmaceutical industry.

Ulrike Sager obtained a Diplom degree in Chemistry from Humboldt-Universität zu Berlin, although the specific start and end years of their education were not provided.